Company / Income Tax per Share
Jade Biosciences, Inc. Income Tax per Share History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.00
FY2024
5-year range
$0.00 / $0.00
FY2021-FY2024
Trend
-9.5%
vs FY2023
Sector context
#102 of 194
Health Care
What the data says
At $0.00, Jade Biosciences, Inc.'s income tax per share ranks #93 of 194 in the Health Care sector. Increased from $0.00 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2024 with a 3-year CAGR of +99.0%.
Increased from $0.00 to $0.00 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +99.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#93 of 194 in Health CareTop 47% of 194This company $0.00 Sector average $1.44
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2024, income tax per share decreased 9.5% year-over-year.
- Ranks #102 out of 194 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.03 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.00 | -9.5% |
| FY2023 | $0.00 | +108.2% |
| FY2022 | $0.00 | +318.6% |
| FY2021 | $0.00 | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026